Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

Abstract Background Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older women initiating BP, we compared the AFF risk associated with treatment fo...

Full description

Bibliographic Details
Main Authors: Joan C. Lo, Romain S. Neugebauer, Bruce Ettinger, Malini Chandra, Rita L. Hui, Susan M. Ott, Christopher D. Grimsrud, Monika A. Izano
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Musculoskeletal Disorders
Subjects:
Femur fracture
Subtrochanter
Femoral shaft
Atypical fracture
Bisphosphonates
Online Access:https://doi.org/10.1186/s12891-020-03672-w

Internet

https://doi.org/10.1186/s12891-020-03672-w

Similar Items